Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Human African Trypanosomiasis) Administered With a Loading Dose and With Food

This study has been terminated.

(poor tolerability at highest dose)

Sponsor:

Information provided by (Responsible Party):

Drugs for Neglected Diseases

ClinicalTrials.gov Identifier:

NCT01483170

First received: November 29, 2011

Last updated: February 10, 2012

Last verified: February 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	February 2012
Primary Completion Date:	December 2011 (Final data collection date for primary outcome measure)